Kestra Advisory Services »

Celldex Therapeutics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $98k 3.6k 27.16

More positions owned by Kestra Advisory Services

Apple (AAPL)
NVIDIA Corporation (NVDA)
Parker-Hannifin Corporation (PH)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Vanguard Index Fds Total Stk Mkt (VTI)
First Tr Exchange Traded Risng Divd Achiv (RDVY)

View all positions for Kestra Advisory Services

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Bellevue Group
State Street Corporation
Commodore Capital
Deep Track Capital
Braidwell
Point72 Asset Management
Eventide Asset Management
Geode Capital Management
Eversept Partners
Novo A/S

View all funds holding Celldex Therapeutics